Rchr
J-GLOBAL ID:200901009590010575   Update date: May. 27, 2020

Ago Yukio

アゴウ ユキオ | Ago Yukio
Affiliation and department:
Job title: Professor
Homepage URL  (2): https://www.hiroshima-u.ac.jp/dent/research/lab/dentistry/Cellular_and_Molecular_Pharmacologyhttps://www.hiroshima-u.ac.jp/en/dent/research/lab/dentistry/Cellular_and_Molecular_Pharmacology
Research field  (4): Pharmacology ,  Pharmacology ,  Pharmacology ,  Pharmaceuticals - health and biochemistry
Research keywords  (5): Glutamate and Glucocorticoid ,  Monoamine ,  Environmental factors ,  Animal models ,  Psychiatric disorders
Research theme for competitive and other funds  (1):
  • 2006 - 2007 Research for the neural basis of combination therapy with SSRI for treatment of schizophrenia
Papers (133):
  • Masato Tanuma, Atsushi Kasai, Kazuki Bando, Naoyuki Kotoku, Kazuo Harada, Masafumi Minoshima, Kosuke Higashino, Atsushi Kimishima, Masayoshi Arai, Yukio Ago, Kaoru Seiriki, Kazuya Kikuchi, Satoshi Kawata, Katsumasa Fujita, Hitoshi Hashimoto. Direct visualization of an antidepressant analog using surface-enhanced Raman scattering in the brain. JCI Insight. 2020
  • Rei Yokoyama, Momoko Higuchi, Wataru Tanabe, Shinji Tsukada, Megumi Naito, Takumi Yamaguchi, Lu Chen, Atsushi Kasai, Kaoru Seiriki, Takanobu Nakazawa, Shinsaku Nakagawa, Kenji Hashimoto, Hitoshi Hashimoto, Yukio Ago. (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression. Pharmacology, biochemistry, and behavior. 2020. 191. 172876-172876
  • Zhiqi Xie, Tamami Ikegami, Yukio Ago, Naoki Okada, Masashi Tachibana. Valproic acid attenuates CCR2-dependent tumor infiltration of monocytic myeloid-derived suppressor cells, limiting tumor progression. Oncoimmunology. 2020. 9. 1. 1734268-1734268
  • Kensuke Matsumura, Masayuki Baba, Kazuki Nagayasu, Kana Yamamoto, Momoka Kondo, Kohei Kitagawa, Tomoya Takemoto, Kaoru Seiriki, Atsushi Kasai, Yukio Ago, Atsuko Hayata-Takano, Norihito Shintani, Toshihiko Kuriu, Tokuichi Iguchi, Makoto Sato, Kazuhiro Takuma, Ryota Hashimoto, Hitoshi Hashimoto, Takanobu Nakazawa. Autism-associated protein kinase D2 regulates embryonic cortical neuron development. Biochemical and Biophysical Research Communications. 2019
  • Masayuki Baba, Kazumasa Yokoyama, Kaoru Seiriki, Yuichiro Naka, Kensuke Matsumura, Momoka Kondo, Kana Yamamoto, Misuzu Hayashida, Atsushi Kasai, Yukio Ago, Kazuki Nagayasu, Atsuko Hayata-Takano, Akinori Takahashi, Shun Yamaguchi, Daisuke Mori, Norio Ozaki, Tadashi Yamamoto, Kazuhiro Takuma, Ryota Hashimoto, Hitoshi Hashimoto, Takanobu Nakazawa. Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome. Neuropsychopharmacology. 2019. 44. 12. 2125
more...
MISC (31):
  • 田熊一敞, 田熊一敞, 田熊一敞, 原雄大, 原雄大, 吾郷由希夫, 橋本均, 橋本均, 橋本均, 橋本均, 中澤敬信, 中澤敬信, 松田敏夫. 前頭葉を標的とする自閉症スペクトラム障害の新たな治療戦略の可能性. 日本臨床精神神経薬理学会プログラム・抄録集. 2018. 28th. 130
  • 三浦大樹, 笠井淳司, 彌永祐輔, 原雄大, 中澤敬信, 中澤敬信, 吾郷由希夫, 田熊一敞, 田熊一敞, 橋本均, 橋本均, 橋本均, 橋本均. 自閉スペクトラム症モデルマウスの社会性行動障害に有効な抗てんかん作用を有する医薬品の探索. 日本薬理学会近畿部会プログラム・要旨集. 2017. 132nd. 31
  • 新谷 紀人, 尾中 勇祐, 叶 拓也, 中澤 敬信, 吾郷 由希夫, 松田 敏夫, 橋本 亮太, 大井 一高, 平井 博之, 永田 欽也, 中村 正孝, 笠井 淳司, 早田 敦子, 野, 永安 一樹, 馬場 明道, 橋本 均. 認知機能制御におけるプロスタグランジンDP2受容体の役割(The role of prostanoid DP2 receptor in the regulation of cognitive function). 日本神経精神薬理学会年会プログラム・抄録集. 2016. 46回. 232-232
  • 吾郷由希夫, 原雄大, 前田優子, 長谷部茂, 橋本均, 橋本均, 松田敏夫, 田熊一敞, 田熊一敞. 自閉症モデルマウスにおける前頭前皮質ドパミン神経系の異常~ADHD治療薬による行動異常の改善. 日本神経精神薬理学会プログラム・抄録集. 2016. 46th. 92
  • 長谷部茂, 原雄大, 樋口桃子, 吾郷由希夫, 中澤敬信, 中澤敬信, 橋本均, 松田敏夫, 田熊一敞, 田熊一敞. ドパミン神経賦活薬の慢性投与は胎仔期バルプロ酸曝露マウスの自閉症様行動を改善する. 日本生物学的精神医学会(Web). 2016. 38th. 175 (WEB ONLY)
more...
Books (2):
  • Neuropathology of Drug Addictions and Substance Misuse, Volume 2: Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants, and International Aspects
    Elsevier 2016
  • Pituitary Adenylate Cyclase Activating Polypeptide - PACAP
    Springer 2016
Education (3):
  • 2003 - 2005 Osaka University Graduate School of Pharmaceutical Sciences Ph.D. course
  • 2001 - 2003 Osaka University Graduate School of Pharmaceutical Sciences M.S. course
  • 1997 - 2001 Osaka University Faculty of Pharmaceutical Sciences
Professional career (1):
  • Ph.D. (Osaka University)
Work history (9):
  • 2020/03 - 現在 Graduate School of Biomedical and Health Sciences, Hiroshima University Professor
  • 2018/04 - 2020/02 Graduate School of Pharmaceutical Sciences, Osaka University Associate Professor
  • 2015/04 - 2018/03 Graduate School of Pharmaceutical Sciences, Osaka University Assistant Professor
  • 2013/07 - 2015/06 (Concurrent post) University of California, Los Angeles Visiting Scholar
  • 2010/04 - 2015/03 Graduate School of Pharmaceutical Sciences, Osaka University Assistant Professor
Show all
Awards (12):
  • 2019/10 - Japanese Society of Neuropsychopharmacology Neuropsychopharmacology Reports Reviewer Award 2019
  • 2018/03 - The Japanese Pharmacological Society Journal of Pharmacological Sciences Excellent Reviewer Award 2017
  • 2016/07 - Japanese Society of Neuropsychopharmacology JSNP Excellent Presentation Award for CINP 2016
  • 2016/05 - The Society for the Study of GPCR Matsuo Award for Encouragement of Young Investigators
  • 2014/07 - Osaka University Osaka University (Japan) Presidential Awards for Encouragement
Show all
Association Membership(s) (9):
THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM ,  American Society for Neurochemistry ,  Collegium Internationale Neuro-Psychopharmacologicum ,  Society for Neuroscience ,  The Pharmaceutical Society of Japan ,  THE JAPANESE SOCIETY FOR NEUROCHEMISTRY ,  THE JAPAN NEUROSCIENCE SOCIETY ,  THE JAPANESE SOCIETY OF NEUROPSYCHOPHARMACOLOGY ,  THE JAPANESE PHARMACOLOGICAL SOCIETY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page